Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
182.6 EUR | -0.27% | -5.14% | -23.74% |
May. 16 | Sartorius sinks again towards year low | DP |
May. 16 | Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day |
Sales 2024 * | 2.94B 3.18B | Sales 2025 * | 3.33B 3.61B | Capitalization | 17.77B 19.28B |
---|---|---|---|---|---|
Net income 2024 * | 335M 363M | Net income 2025 * | 451M 489M | EV / Sales 2024 * | 6.83 x |
Net Debt 2024 * | 2.27B 2.46B | Net Debt 2025 * | 2.16B 2.34B | EV / Sales 2025 * | 5.99 x |
P/E ratio 2024 * |
51.4
x | P/E ratio 2025 * |
37
x | Employees | 10,493 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.6% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | -0.27% | ||
1 week | -5.14% | ||
1 month | -10.02% | ||
3 months | -28.18% | ||
6 months | -11.51% | ||
Current year | -23.74% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 17 M€ | +6.09% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 182.6 | -0.27% | 167,808 |
24-05-30 | 183.2 | -0.68% | 53,302 |
24-05-29 | 184.4 | -1.13% | 79,127 |
24-05-28 | 186.5 | -0.61% | 61,198 |
24-05-27 | 187.6 | -2.54% | 71,553 |
Real-time Euronext Paris, May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.74% | 19.28B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- DIM Stock